BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025 AND Treatment
14 results:

  • 1. DNA Repair Pathway in Ovarian cancer Patients Treated with HIPEC.
    Flasarova D; Urban K; Strouhal O; Klos D; Lemstrova R; Dvorak P; Soucek P; Mohelnikova-Duchonova B
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240218
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Increased levels of xpa might be the basis of cisplatin resistance in germ cell tumours.
    Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
    BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    Yoshii Y; Matsumoto H; Yoshimoto M; Oe Y; Zhang MR; Nagatsu K; Sugyo A; Tsuji AB; Higashi T
    J Nucl Med; 2019 Oct; 60(10):1437-1443. PubMed ID: 30850497
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Enhanced antitumor efficacy of ultrasonic cavitation with up-sized microbubbles in pancreatic cancer.
    Huang P; Zhang Y; Chen J; Shentu W; Sun Y; Yang Z; Liang T; Chen S; Pu Z
    Oncotarget; 2015 Aug; 6(24):20241-51. PubMed ID: 26036312
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association between ERCC1 and xpa expression and polymorphisms and the response to cisplatin in testicular germ cell tumours.
    Mendoza J; Martínez J; Hernández C; Pérez-Montiel D; Castro C; Fabián-Morales E; Santibáñez M; González-Barrios R; Díaz-Chávez J; Andonegui MA; Reynoso N; Oñate LF; Jiménez MA; Núñez M; Dyer R; Herrera LA
    Br J Cancer; 2013 Jul; 109(1):68-75. PubMed ID: 23807173
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis.
    McElroy MK; Kaushal S; Tran Cao HS; Moossa AR; Talamini MA; Hoffman RM; Bouvet M
    Mol Cancer Ther; 2009 Jul; 8(7):1779-86. PubMed ID: 19584238
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer.
    Snyder CS; Kaushal S; Kono Y; Tran Cao HS; Hoffman RM; Bouvet M
    BMC Cancer; 2009 Apr; 9():106. PubMed ID: 19351417
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
    Saldivar JS; Lu KH; Liang D; Gu J; Huang M; Vlastos AT; Follen M; Wu X
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S223-9. PubMed ID: 17825393
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1).
    Lind GE; Skotheim RI; Fraga MF; Abeler VM; Esteller M; Lothe RA
    J Pathol; 2006 Dec; 210(4):441-9. PubMed ID: 17029216
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10.
    Hector S; Nava ME; Clark K; Murphy M; Pendyala L
    Cancer Lett; 2007 Jan; 245(1-2):195-204. PubMed ID: 16516375
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma.
    Stevens EV; Raffeld M; Espina V; Kristensen GB; Trope' CG; Kohn EC; Davidson B
    Cancer; 2005 Jun; 103(11):2313-9. PubMed ID: 15844177
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Xeroderma pigmentosum group a protein and chemotherapy resistance in human germ cell tumors.
    Honecker F; Mayer F; Stoop H; Oosterhuis JW; Koch S; Bokemeyer C; Looijenga LH
    Lab Invest; 2003 Oct; 83(10):1489-95. PubMed ID: 14563950
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Defective repair of cisplatin-induced DNA damage caused by reduced xpa protein in testicular germ cell tumours.
    Köberle B; Masters JR; Hartley JA; Wood RD
    Curr Biol; 1999 Mar; 9(5):273-6. PubMed ID: 10074455
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Enhanced xpa mRNA levels in cisplatin-resistant human ovarian cancer are not associated with xpa mutations or gene amplification.
    States JC; Reed E
    Cancer Lett; 1996 Nov; 108(2):233-7. PubMed ID: 8973600
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.